5kgw - Revision history

OCA at 10:46, 27 September 2023

OCA — Wed, 27 Sep 2023 10:46:27 GMT

←Older revision		Revision as of 10:46, 27 September 2023
Line 3:		Line 3:
	<StructureSection load='5kgw' size='340' side='right'caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>		<StructureSection load='5kgw' size='340' side='right'caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~9hiv1 9hiv1~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5KGW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5KGW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=~~SO4~~:~~SULFATE+ION~~'>~~SO4~~</scene>~~</td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.34Å</td></tr>
-	~~<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat">~~<scene name='pdbligand=~~CAF~~:~~S-DIMETHYLARSINOYL-CYSTEINE~~'>~~CAF~~</scene></td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [~~http~~://pdbe.org/5kgw PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [https://pdbe.org/5kgw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [https://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>
	</table>		</table>
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/POL_HV1N5 POL_HV1N5] Gag-Pol polyprotein and Gag polyprotein may regulate their own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, Gag-Pol and Gag would promote translation, whereas at high concentration, the polyproteins encapsidate genomic RNA and then shutt off translation (By similarity). Matrix protein p17 has two main functions: in infected cell, it targets Gag and Gag-pol polyproteins to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus. The second function is to play a role in nuclear localization of the viral genome at the very start of cell infection. Matrix protein is the part of the pre-integration complex. It binds in the cytoplasm the human BAF protein which prevent autointegration of the viral genome, and might be included in virions at the ration of zero to 3 BAF dimer per virion. The myristoylation signal and the NLS thus exert conflicting influences its subcellular localization. The key regulation of these motifs might be phosphorylation of a portion of MA molecules on the C-terminal tyrosine at the time of virus maturation, by virion-associated cellular tyrosine kinase. Implicated in the release from host cell mediated by Vpu (By similarity). Capsid protein p24 forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion. Most core are conical, with only 7% tubular. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry. Interaction with human PPIA/CYPA protects the virus from restriction by human TRIM5-alpha and from an unknown antiviral activity in human cells. This capsid restriction by TRIM5 is one of the factors which restricts HIV-1 to the human species (By similarity). Nucleocapsid protein p7 encapsulates and protects viral dimeric unspliced (genomic) RNA. Binds these RNAs through its zinc fingers. Facilitates rearangement of nucleic acid secondary structure during retrotranscription of genomic RNA. This capability is referred to as nucleic acid chaperone activity (By similarity). The aspartyl protease mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane. Cleavages take place as an ordered, step-wise cascade to yield mature proteins. This process is called maturation. Displays maximal activity during the budding process just prior to particle release from the cell. Also cleaves Nef and Vif, probably concomitantly with viral structural proteins on maturation of virus particles (By similarity). Reverse transcriptase/ribonuclease H (RT) is a multifunctional enzyme that converts the viral RNA genome into dsDNA in the cytoplasm, shortly after virus entry into the cell. This enzyme displays a DNA polymerase activity that can copy either DNA or RNA templates, and a ribonuclease H (RNase H) activity that cleaves the RNA strand of RNA-DNA heteroduplexes in a partially processive 3' to 5' endonucleasic mode. Conversion of viral genomic RNA into dsDNA requires many steps. A tRNA(3)-Lys binds to the primer-binding site (PBS) situated at the 5'-end of the viral RNA. RT uses the 3' end of the tRNA primer to perform a short round of RNA-dependent minus-strand DNA synthesis. The reading proceeds through the U5 region and ends after the repeated (R) region which is present at both ends of viral RNA. The portion of the RNA-DNA heteroduplex is digested by the RNase H, resulting in a ssDNA product attached to the tRNA primer. This ssDNA/tRNA hybridizes with the identical R region situated at the 3' end of viral RNA. This template exchange, known as minus-strand DNA strong stop transfer, can be either intra- or intermolecular. RT uses the 3' end of this newly synthesized short ssDNA to perform the RNA-dependent minus-strand DNA synthesis of the whole template. RNase H digests the RNA template except for two polypurine tracts (PPTs) situated at the 5'-end and near the center of the genome. It is not clear if both polymerase and RNase H activities are simultaneous. RNase H probably can proceed both in a polymerase-dependent (RNA cut into small fragments by the same RT performing DNA synthesis) and a polymerase-independent mode (cleavage of remaining RNA fragments by free RTs). Secondly, RT performs DNA-directed plus-strand DNA synthesis using the PPTs that have not been removed by RNase H as primers. PPTs and tRNA primers are then removed by RNase H. The 3' and 5' ssDNA PBS regions hybridize to form a circular dsDNA intermediate. Strand displacement synthesis by RT to the PBS and PPT ends produces a blunt ended, linear dsDNA copy of the viral genome that includes long terminal repeats (LTRs) at both ends (By similarity). Integrase catalyzes viral DNA integration into the host chromosome, by performing a series of DNA cutting and joining reactions. This enzyme activity takes place after virion entry into a cell and reverse transcription of the RNA genome in dsDNA. The first step in the integration process is 3' processing. This step requires a complex comprising the viral genome, matrix protein, Vpr and integrase. This complex is called the pre-integration complex (PIC). The integrase protein removes 2 nucleotides from each 3' end of the viral DNA, leaving recessed CA OH's at the 3' ends. In the second step, the PIC enters cell nucleus. This process is mediated through integrase and Vpr proteins, and allows the virus to infect a non dividing cell. This ability to enter the nucleus is specific of lentiviruses, other retroviruses cannot and rely on cell division to access cell chromosomes. In the third step, termed strand transfer, the integrase protein joins the previously processed 3' ends to the 5' ends of strands of target cellular DNA at the site of integration. The 5'-ends are produced by integrase-catalyzed staggered cuts, 5 bp apart. A Y-shaped, gapped, recombination intermediate results, with the 5'-ends of the viral DNA strands and the 3' ends of target DNA strands remaining unjoined, flanking a gap of 5 bp. The last step is viral DNA integration into host chromosome. This involves host DNA repair synthesis in which the 5 bp gaps between the unjoined strands are filled in and then ligated. Since this process occurs at both cuts flanking the HIV genome, a 5 bp duplication of host DNA is produced at the ends of HIV-1 integration. Alternatively, Integrase may catalyze the excision of viral DNA just after strand transfer, this is termed disintegration (By similarity).
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 24:		Line 26:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human immunodeficiency virus 1]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Feng, L]]	+	[[Category: Feng L]]
-	[[Category: Kobe, M]]	+	[[Category: Kobe M]]
-	[[Category: Kvaratskhelia, M]]	+	[[Category: Kvaratskhelia M]]
-	~~[[Category: Integrase allini nucleic acid binding]]~~	+
-	~~[[Category: Transferase-transferase inhibitor complex~~]]	+

OCA at 15:24, 8 July 2020

OCA — Wed, 08 Jul 2020 15:24:57 GMT

←Older revision		Revision as of 15:24, 8 July 2020
Line 1:		Line 1:

	==HIV1 catalytic core domain in complex with inhibitor: (2~{S})-2-[3-(3,4-dihydro-2~{H}-chromen-6-yl)-1-methyl-indol-2-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid==		==HIV1 catalytic core domain in complex with inhibitor: (2~{S})-2-[3-(3,4-dihydro-2~{H}-chromen-6-yl)-1-methyl-indol-2-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid==
-	<StructureSection load='5kgw' size='340' side='right' caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>	+	<StructureSection load='5kgw' size='340' side='right'caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5KGW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5KGW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [http://pdbe.org/5kgw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [http://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [http://pdbe.org/5kgw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [http://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 17:		Line 17:
	</div>		</div>
	<div class="pdbe-citations 5kgw" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5kgw" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Retroviral integrase 3D structures\|Retroviral integrase 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Feng, L]]		[[Category: Feng, L]]
	[[Category: Kobe, M]]		[[Category: Kobe, M]]

OCA at 06:07, 8 March 2018

OCA — Thu, 08 Mar 2018 06:07:42 GMT

←Older revision		Revision as of 06:07, 8 March 2018
Line 3:		Line 3:
	<StructureSection load='5kgw' size='340' side='right' caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>		<StructureSection load='5kgw' size='340' side='right' caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KGW FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/9hiv1 9hiv1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KGW FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>

OCA at 11:15, 2 November 2016

OCA — Wed, 02 Nov 2016 11:15:32 GMT

←Older revision		Revision as of 11:15, 2 November 2016
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KGW FirstGlance]. <br>		<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KGW FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=~~6SK~~:(3~~~{S},~~3~~~{S}~~,4~~~{S})~~-4-~~AZANYL~~-6-~~CHLORANYL~~-3-~~(3-CHLOROPHENYL~~)-1-~~(2,2~~-~~DIMETHYLPROPYL)SPIRO[1~{H}~~-~~INDOLE~~-3,2-~~PYRROLIDINE~~]~~-2-ONE~~'>~~6SK~~</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7SK:(2S)-TERT-BUTOXY[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-1-METHYL-1H-INDOL-2-YL]ACETIC+ACID'>7SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>		<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [http://pdbe.org/5kgw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [http://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [http://pdbe.org/5kgw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [http://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>

OCA at 17:25, 19 October 2016

OCA — Wed, 19 Oct 2016 17:25:04 GMT

←Older revision		Revision as of 17:25, 19 October 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 5kgw is ~~ON HOLD until Paper~~ Publication	+	==HIV1 catalytic core domain in complex with inhibitor: (2~{S})-2-[3-(3,4-dihydro-2~{H}-chromen-6-yl)-1-methyl-indol-2-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid==
		+	<StructureSection load='5kgw' size='340' side='right' caption='[[5kgw]], [[Resolution\|resolution]] 2.34Å' scene=''>
		+	== Structural highlights ==
		+	<table><tr><td colspan='2'>[[5kgw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5KGW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5KGW FirstGlance]. <br>
		+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6SK:(3~{S},3~{S},4~{S})-4-AZANYL-6-CHLORANYL-3-(3-CHLOROPHENYL)-1-(2,2-DIMETHYLPROPYL)SPIRO[1~{H}-INDOLE-3,2-PYRROLIDINE]-2-ONE'>6SK</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
		+	<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue\|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CAF:S-DIMETHYLARSINOYL-CYSTEINE'>CAF</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5kgw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5kgw OCA], [http://pdbe.org/5kgw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5kgw RCSB], [http://www.ebi.ac.uk/pdbsum/5kgw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5kgw ProSAT]</span></td></tr>
		+	</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Employing a scaffold hopping approach, a series of allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) have been synthesized based on an indole scaffold. These compounds incorporate the key elements utilized in quinoline-based ALLINIs for binding to the IN dimer interface at the principal LEDGF/p75 binding pocket. The most potent of these compounds displayed good activity in the LEDGF/p75 dependent integration assay (IC50=4.5muM) and, as predicted based on the geometry of the five- versus six-membered ring, retained activity against the A128T IN mutant that confers resistance to many quinoline-based ALLINIs.

-	~~Authors~~:	+	Indole-based allosteric inhibitors of HIV-1 integrase.,Patel PA, Kvaratskhelia N, Mansour Y, Antwi J, Feng L, Koneru P, Kobe MJ, Jena N, Shi G, Mohamed MS, Li C, Kessl JJ, Fuchs JR Bioorg Med Chem Lett. 2016 Oct 1;26(19):4748-52. doi: 10.1016/j.bmcl.2016.08.037., Epub 2016 Aug 13. PMID:27568085<ref>PMID:27568085</ref>

-	~~Description~~:	+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
-	[[Category: ~~Unreleased Structures~~]]	+	</div>
		+	<div class="pdbe-citations 5kgw" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Feng, L]]
		+	[[Category: Kobe, M]]
		+	[[Category: Kvaratskhelia, M]]
		+	[[Category: Integrase allini nucleic acid binding]]
		+	[[Category: Transferase-transferase inhibitor complex]]

OCA at 00:20, 13 July 2016

OCA — Wed, 13 Jul 2016 00:20:34 GMT

←Older revision		Revision as of 00:20, 13 July 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5kgw is ON HOLD	+	The entry 5kgw is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "5kgw" [edit=sysop:move=sysop]

OCA — Thu, 23 Jun 2016 21:35:36 GMT

Protected "5kgw" [edit=sysop:move=sysop]

←Older revision

Revision as of 21:35, 23 June 2016

OCA: New page: '''Unreleased structure''' The entry 5kgw is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Thu, 23 Jun 2016 21:35:35 GMT

New page: '''Unreleased structure''' The entry 5kgw is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 5kgw is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]